<?xml version="1.0" encoding="UTF-8"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-10-18T23:53:58Z</responseDate><request verb="GetRecord" identifier="oai:ebyu-rdlopen.rawdatalibrary.net:ebyu/10088" metadataPrefix="oai_dc">https://ebyu-rdlopen.rawdatalibrary.net/oai/request</request><GetRecord><record><header><identifier>oai:ebyu-rdlopen.rawdatalibrary.net:ebyu/10088</identifier><datestamp>2026-10-18T20:41:29Z</datestamp><setSpec>openaire</setSpec><setSpec>driver</setSpec><setSpec>com_ebyu_10000</setSpec><setSpec>col_ebyu_10001</setSpec></header><metadata><oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd"><dc:title>The effect of povidone-iodine-enhanced rectal enema on procedure-related infectious complications before transrectal ultrasound-guided prostate biopsy: A prospective randomized study</dc:title><dc:creator>Doğan, Mücahit</dc:creator><dc:creator>Aydin, Cemil</dc:creator><dc:creator>Ekici, Musa</dc:creator><dc:creator>Çağlayan, Mustafa Serdar</dc:creator><dc:creator>Öztürk, Muhammet İhsan</dc:creator><dc:creator>Baykam, Mehmet Murat</dc:creator><dc:subject>enema</dc:subject><dc:subject>infectious complications</dc:subject><dc:subject>povidone-iodine</dc:subject><dc:subject>prostate cancer</dc:subject><dc:subject>rectal cleansing</dc:subject><dc:subject>transrectal prostate biopsy</dc:subject><dc:subject>urinary tract infection</dc:subject><dc:subject>Aged</dc:subject><dc:subject>Anti-Infective Agents, Local</dc:subject><dc:subject>Humans</dc:subject><dc:subject>Image-Guided Biopsy</dc:subject><dc:subject>Male</dc:subject><dc:subject>Middle Aged</dc:subject><dc:subject>Phosphates</dc:subject><dc:subject>Postoperative Complications</dc:subject><dc:subject>Prospective Studies</dc:subject><dc:subject>Prostate</dc:subject><dc:subject>Prostatic Neoplasms</dc:subject><dc:subject>Rectum</dc:subject><dc:subject>Ultrasonography, Interventional</dc:subject><dc:subject>antibiotic agent</dc:subject><dc:subject>cefixime</dc:subject><dc:subject>povidone iodine</dc:subject><dc:subject>prilocaine</dc:subject><dc:subject>prostate specific antigen</dc:subject><dc:subject>sodium dihydrogen phosphate</dc:subject><dc:subject>phosphate</dc:subject><dc:subject>topical antiinfective agent</dc:subject><dc:subject>antibiotic prophylaxis</dc:subject><dc:subject>Article</dc:subject><dc:description>Background: – To prospectively evaluate the effects of rectal cleansing using a povidone-iodine (PI) and PI enhanced rectal enema on procedure-related infectious complications in patients undergoing transrectal prostate biopsy. Methods: – Between September 2023 and March 2024, patients scheduled for their first transrectal ultrasound-guided prostate biopsy due to elevated prostate-specific antigen levels, suspicious multiparametric prostate magnetic resonance imaging findings, or abnormal digital rectal examination were prospectively randomized into 2 groups (n = 60 each). All patients received standard prophylactic measures, including antibiotic prophylaxis starting 1 day prior to the procedure and rectal mucosal cleansing with PI immediately before biopsy. Both groups additionally underwent rectal enema administration. In the intervention group, a PI enhanced rectal enema was administered by adding PI to the sodium phosphate enema solution, whereas the control group received a sodium phosphate enema alone. Post-procedural complications, including hematuria, hematospermia, rectal bleeding, fever, acute urinary retention, hospitalization, sepsis, and urine and blood culture results, were recorded and compared using chi-square tests. Results: – In total of 120 patients were enrolled. The mean age in both groups was 66.6 years (± 7.20). Hospitalization due to febrile urinary tract infection occurred in 6 patients (10%) in the control group versus 2 patients (3.3%) in the study group. Positive urine cultures were found in 6 patients (10%) in the control group, while no positive cultures were detected in the study group, a statistically significant difference (P = .046). No significant differences were observed between the groups in terms of hematuria, hematospermia, rectal bleeding or acute urinary retention. Conclusion: – Rectal cleansing with a PI and PI enhanced rectal enema prior to transrectal prostate biopsy significantly reduced the rate of positive urine cultures. Although the reductions in febrile urinary tract infections and sepsis-related hospitalizations were not statistically significant, the overall trend suggests a potential benefit. Given that infectious complications are the most common adverse events associated with transrectal biopsy, this simple and low-cost intervention may improve patient safety. © 2026 the Author(s). Published by Wolters Kluwer Health, Inc.</dc:description><dc:publisher>Lippincott Williams and Wilkins</dc:publisher><dc:date>2026</dc:date><dc:type>Article</dc:type><dc:identifier>https://rdlopen.rawdatalibrary.net/r/ebyu/10088</dc:identifier><dc:identifier>https://doi.org/10.1097/md.0000000000048830</dc:identifier><dc:identifier>0025-7974</dc:identifier><dc:language>en</dc:language><dc:relation>Medicine (United States)</dc:relation><dc:rights>info:eu-repo/semantics/openAccess</dc:rights><dc:type>info:eu-repo/semantics/article</dc:type><dc:identifier>https://ebyu-rdlopen.rawdatalibrary.net/tr/items/ebyu/10088</dc:identifier></oai_dc:dc></metadata></record></GetRecord></OAI-PMH>